- Dow Jones nears best monthly gain since 1987
- Nikola (NKLA.US) stocks slide 20% after updated deal with General Motors (GM.US)
- Moderna (MRNA.US) files for drug approval
US100 is testing the lower limit of the upward channel. If sellers manage to break below, a bigger downward correction may start. The nearest support lies at 12 070 pts and is additionally strengthened by 50 SMA ( green line). However if buyers will managed to uphold momentum then another upward impulse towards resistance at 12 400 pts could be launched. Source: xStation5
Nikola (NKLA.US) stock plunged 20.0% in premarket trading, after the battery- and hydrogen-electric vehicle maker signed smaller reworked, deal with General Motors (GM.US) that abandons plans to build the electric pickup the Badger. Also GM won’t be taking a stake in Nikola. In September, both companies announced a $2 billion deal that gave GM an 11% stake in Nikola for supplying battery and fuel cell technologies as well as producing the pickup.
Moderna (MRNA.US)— stock jumped 11% in premarket after company announced that according to new data its COVID-19 vaccine showed over 94% effectiveness. Today drugmaker is planning to request emergency clearance from the Food and Drug Administration.
Slack (WORK.US) stock fell over 2% in premarket trading after Barclays downgraded shares of the messaging platform to “equal weight” from “overweight”. Barclays believes that acquisition from Salesforce would cause limited upside for Slack shares.
Bank of America (BAC.US), JPMorgan (JPM.US), Goldman Sachs (GS.US)— bank stocks fell in premarket trading after Morgan Stanley (MS.US) downgraded their ratings, favoring other consumer banks heading into 2021. Both Bank of America and JPMorgan were downgraded from to “underweight” from “overweight” and Goldman Sachs to “underweight” from “equal weight.”